Uni Eropa - Cheska - EMA (European Medicines Agency)

roche registration gmbh - mosunetuzumab - lymfom, folikulární - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Uni Eropa - Cheska - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - mnohočetný myelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Republik Cheska - Cheska - SUKL (Státní ústav pro kontrolu léčiv)

noridem enterprises limited, nikosia array - 453 sodnÁ sŮl dexamethason-fosfÁtu - injekční roztok - 4mg/ml - dexamethason